Friday, February 14, 2025
Home Tags Sensorion

Tag: Sensorion

Sensorion Submits Clinical Trial Application for Lead Gene Therapy Candidate OTO…...

0
Regulatory News: Sensorion (FR0012596468 – ALSEN) ALSEN a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and...

Sensorion Provides Preliminary Documents for the Combined Shareholders’ General … –...

0
Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in gene therapies in the inner ear, announces that the Company's...

Sensorion Announces the Publication of Its 2022 Annual Financial Report ...

0
Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in gene therapies in the inner ear, announces that its Annual...

Sensorion Reports Full-Year 2022 Financial Results and Business Update –...

0
CTA filing for OTOF-GT planned for Q2 2023 Presented new preclinical data supporting continued progress of OTOF-GT, and potential for safe and efficient clinical...

Sensorion Will Present Two Posters at the Association for Research in...

0
Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent...

Sensorion Full-Year 2021 Financial Results and Business Highlights – Benzinga –...

0
Accelerating development of the OTOF-GT and GJB2-GT gene therapy programs in collaboration with Institut Pasteur Advancing SENS-401 joint clinical development program with Cochlear Ltd....

Sensorion Provides Preliminary Documents for the Extraordinary General Meeting o… –...

0
Regulatory News: Sensorion (FR0012596468 – ALSEN) ALSEN a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and...

Sensorion Will Present at the Bioprocessing Summit Europe Conference on March...

0
Regulatory News: Sensorion ALSEN (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and...

Press Realease

Business News

Cricket

Weather News

Lifestyle

World News

UK / USA News

Local News